Background In spite of several research studies help to describe the heart in Fabry disease (FD), the car-diomyopathy is not entirely understood. In addition, the impact of blood pressure and alter-ations in geometry have not been systematically evaluated. Methods In 74 FD patients (mean age 36±12 years; 45 females) the extent of myocardial fibrosis and its progression were quantified using cardiac magnetic-resonance-imaging with late enhancement technique (LE). Results were compared to standard echocardiography com-plemented by 2D-speckle-tracking, 3D-sphericity-index (SI) and standardized blood pres-sure measurement. At baseline, no patient received enzyme replacement therapy (ERT). After 51±24 months, a follow-up examination was performe...
Background: Fabry disease is a lysosomal storage disease caused by enzyme α-galactosidase A deficien...
PURPOSE: Whether cardiac sympathetic nervous function abnormalities may be present in patients with ...
ObjectivesWe hypothesized that Fabry cardiomyopathy in female patients might differ substantially fr...
BACKGROUND/nIn spite of several research studies help to describe the heart in Fabry disease (FD), t...
In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyo...
Background In spite of several research studies help to describe the heart in Fabry disease (FD), ...
The aim of this study was to investigate the impact of myocardial fibrosis in Fabry disease. Seventy...
BACKGROUND: Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in pat...
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disease resulting in tissue accumula...
Background: In prehypertrophic Fabry disease, low myocardial T1 values, reflecting sphingolipid stor...
Fabry disease (FD) is an X-linked inheritable storage disease caused by a deficiency of alpha-galact...
Fabry disease (FD) is an X-linked genetic disorder of glycosphingolipid metabolism due to deficiency...
Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, ...
International audiencePURPOSE:To evaluate the potential of non-contrast myocardial T1 mapping on car...
Echocardiography plays a key role in the evaluation of functional and structural changes of the hear...
Background: Fabry disease is a lysosomal storage disease caused by enzyme α-galactosidase A deficien...
PURPOSE: Whether cardiac sympathetic nervous function abnormalities may be present in patients with ...
ObjectivesWe hypothesized that Fabry cardiomyopathy in female patients might differ substantially fr...
BACKGROUND/nIn spite of several research studies help to describe the heart in Fabry disease (FD), t...
In spite of several research studies help to describe the heart in Fabry disease (FD), the cardiomyo...
Background In spite of several research studies help to describe the heart in Fabry disease (FD), ...
The aim of this study was to investigate the impact of myocardial fibrosis in Fabry disease. Seventy...
BACKGROUND: Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in pat...
BACKGROUND: Fabry disease (FD) is an X-linked lysosomal storage disease resulting in tissue accumula...
Background: In prehypertrophic Fabry disease, low myocardial T1 values, reflecting sphingolipid stor...
Fabry disease (FD) is an X-linked inheritable storage disease caused by a deficiency of alpha-galact...
Fabry disease (FD) is an X-linked genetic disorder of glycosphingolipid metabolism due to deficiency...
Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, ...
International audiencePURPOSE:To evaluate the potential of non-contrast myocardial T1 mapping on car...
Echocardiography plays a key role in the evaluation of functional and structural changes of the hear...
Background: Fabry disease is a lysosomal storage disease caused by enzyme α-galactosidase A deficien...
PURPOSE: Whether cardiac sympathetic nervous function abnormalities may be present in patients with ...
ObjectivesWe hypothesized that Fabry cardiomyopathy in female patients might differ substantially fr...